fisetin
Selected indexed studies
- Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases. (Mech Ageing Dev, 2024) [PMID:39384074]
- Fisetin is a senotherapeutic that extends health and lifespan. (EBioMedicine, 2018) [PMID:30279143]
- Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. (Acta Pharmacol Sin, 2024) [PMID:37696989]
_Worker-drafted node — pending editorial review._
Connections
fisetin helps
fisetin protects against
Sources
- Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases. (2024) pubmed
- Fisetin is a senotherapeutic that extends health and lifespan. (2018) pubmed
- Fisetin ameliorates fibrotic kidney disease in mice via inhibiting ACSL4-mediated tubular ferroptosis. (2024) pubmed
- Fisetin: hormesis accounts for many of its chemoprotective effects. (2025) pubmed
- Fisetin ameliorates cognitive impairment by activating mitophagy and suppressing neuroinflammation in rats with sepsis-associated encephalopathy. (2022) pubmed
- Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence. (2024) pubmed
- Natural flavonol fisetin attenuated hyperuricemic nephropathy via inhibiting IL-6/JAK2/STAT3 and TGF-β/SMAD3 signaling. (2021) pubmed
- Dual targeting of mTOR/IL-17A and autophagy by fisetin alleviates psoriasis-like skin inflammation. (2022) pubmed
- Role of Fisetin in Selected Malignant Neoplasms in Women. (2023) pubmed
- Flavonoid fisetin alleviates kidney inflammation and apoptosis via inhibiting Src-mediated NF-κB p65 and MAPK signaling pathways in septic AKI mice. (2020) pubmed